(AUGUST 2, 2019) Healio.com highlighted research conducted by Assistant Professor of Surgery Thomas P. Ahern, Ph.D., M.P.H., and colleagues in an article, titled "Certain medications linked to increased breast cancer risk." The piece summarizes an study published by Ahern and colleagues in the Journal of Clinical Oncology
on phthalate exposure and breast cancer incidence. Ahern wrote that “Preclinical evidence suggests that some phthalates promote breast tumor growth through ER signaling. Estrogen-independent breast cancer promotion mechanisms have also been reported for phthalates, as have antiestrogenic effects.”
Read the full article in Healio here >>.
Read the study in Journal of Clinical Oncology here>>.